D003123DisordersC04.588.274.476.411.307.190C04.700.250C06.301.371.411.307.190C06.405.249.411.307.190C06.405.469.158.356.190C06.405.469.491.307.190C16.320.700.250C18.452.284.2551303820.711398Colorectal Neoplasms, Hereditary Nonpolyposiscatalyst:eCommonsLogineCommons LoginFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson12.13270.0111283130research area of0.9726730.0350088284subject area forMedicineGastroenterologyOncologyDana-Farber Cancer InstituteMassachusetts General HospitalMBY2MatthewYurgelunMatthew Boland Yurgelun, M.D.42.34022770000000-71.1058540000000071749Yurgelun, MatthewAssociate Professor of MedicineSS22SapnaSyngalSapna Syngal, M.D.42.33789600000000-71.1072493000000063537Syngal, SapnaProfessor of MedicineDCC7DanielChungDaniel C. Chung, M.D.42.36258150000000-71.067024000000004594Chung, DanielProfessor of Medicinetrue1Professor of MedicineProfessor of Medicinetrue1Professor of MedicineProfessor of Medicinetrue1Research Associate in MedicineResearch Associate in Medicinetrue1Associate Professor of MedicineAssociate Professor of Medicinetrue1Assistant Professor of MedicineAssistant Professor of Medicine37402979Boland CR, Koi M, Hawn MT, Carethers JM, Yurgelun MBDigestive diseases and sciencesSerendipity Strikes: How Pursuing Novel Hypotheses Shifted the Paradigm Regarding the Genetic Basis of Colorectal Cancer and Changed Cancer Therapy. Dig Dis Sci. 2023 09; 68(9):3504-3513.Dig Dis Sci2023-07-05T00:00:002023Serendipity Strikes: How Pursuing Novel Hypotheses Shifted the Paradigm Regarding the Genetic Basis of Colorectal Cancer and Changed Cancer Therapy.37140568Biller LH, Ng KJournal of the National Cancer InstituteThe "scope" of colorectal cancer screening in Lynch syndrome: is there an optimal interval? J Natl Cancer Inst. 2023 07 06; 115(7):775-777.J Natl Cancer Inst2023-07-06T00:00:002023The "scope" of colorectal cancer screening in Lynch syndrome: is there an optimal interval?37639653Lau-Min KS, Bleznuck J, Wollack C, McKenna DB, Long JM, Hubert AP, Johnson M, Rochester SE, Constantino G, Dudzik C, Doucette A, Wangensteen K, Domchek SM, Landgraf J, Chen J, Nathanson KL, Katona BWJCO clinical cancer informaticsDevelopment of an Electronic Health Record-Based Clinical Decision Support Tool for Patients With Lynch Syndrome. JCO Clin Cancer Inform. 2023 08; 7:e2300024.JCO Clin Cancer Inform2023-08-01T00:00:002023Development of an Electronic Health Record-Based Clinical Decision Support Tool for Patients With Lynch Syndrome.37572151Sandoval RL, Horiguchi M, Ukaegbu C, Furniss CS, Uno H, Syngal S, Yurgelun MBFamilial cancerPREMM5 distinguishes sporadic from Lynch syndrome-associated MMR-deficient/MSI-high colorectal cancer. Fam Cancer. 2023 10; 22(4):459-465.Fam Cancer2023-08-12T00:00:002023PREMM5 distinguishes sporadic from Lynch syndrome-associated MMR-deficient/MSI-high colorectal cancer.37724990Deng N, Reyes-Uribe L, Fahrmann JF, Thoman WS, Munsell MF, Dennison JB, Murage E, Wu R, Hawk ET, Thirumurthi S, Lynch PM, Dieli-Conwright CM, Lazar AJ, Jindal S, Chu K, Chelvanambi M, Basen-Engquist K, Li Y, Wargo JA, McAllister F, Allison JP, Sharma P, Sinha KM, Hanash S, Gilchrist SC, Vilar EClinical cancer research : an official journal of the American Association for Cancer ResearchExercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome. Clin Cancer Res. 2023 11 01; 29(21):4361-4372.Clin Cancer Res2023-11-01T00:00:002023Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome.LB153LeahBillerLeah Biller, M.D.120362Biller, LeahAssistant Professor of Medicine2Assistant Professor1Associate Professor0Full Professor5Other FacultyCU6ChineduUkaegbuChinedu Iheyinwa Ukaegbu, M.B.,B.S.88716Ukaegbu, ChineduResearch Associate in Medicine